Special Source Operations Weekly – 18 April 2013

Open PDF
Creating agency: NSA National Security Agency (US)
Document date: 2013-04-18
Pages: 3
Genre: slides
Banner:
Classification: TOP SECRET SI
Dissemination: NOFORN

Long Description:
No extended description available.
Programs:
PRISM, SSO

People mentioned:
-

Countries:
Iran

Tags:
-

Identifier:
NCMI-Pages-U18April2013-SSO-WeeklyBrief-v1-0

PDF SHA-256:
df03ba2cfe8bc0498d447f3b9313eb64078cf2aff5d36a0385c5fc003db83995

UNCLASSIFIED//FOR OFFICIAL USE ONLY

18 APRIL 2013

Special Source Operations Weekly

UNCLASSIFIED//FOR OFFICIAL USE ONLY


UNCLASSIFIED//FOR OFFICIAL USE ONLY

The overall classification of this briefing is:
TOP SECRET//SI//ORCON/NOFORN

Approval for dissemination of information
contained in this briefing,
in whole or in part, is required.

DERIVED FROM: NSA/CSSM 1-52
DATED: 20070108
DECLASSIFY ON: 20360901
UNCLASSIFIED//FOR OFFICIAL USE ONLY


TOP SECRET//SI//NOFORN

(TS//SI//NF) PRISM Reporting Highlight

Insight provided into Iranian CBW-related Research

  • Between January and March 2013, S2G12's Iran Chemical and Biological Warfare (CBW) team issued five sole-source (PRISM) reports
    • Consisted of scientific research papers detailing activities conducted at Iran's Tehran University of Medical Sciences and Baghyatollah Medical Sciences University
    • Both universities, which are suspected of being linked to Iranian CBW programs
    • Highlighting Iran's human trials research involving patients exposed to organophosphorous (OP) compounds in pesticides and development of treatment creams
      • Could also be used in the event of OP nerve agent exposure.

TOP SECRET//SI//NOFORN

(TS//SI//REL TO USA, FVEY) Between January and March 2013, S2G12's Iran Chemical and Biological Warfare (CBW) team issued 5 reports, all sole-sourced to FAA traffic, which consisted of scientific research papers detailing activities conducted at Iran's Tehran University of Medical Sciences and Baghyatollah Medical Sciences University. Reporting on these two universities, which are suspected of being linked to Iranian CBW programs, highlighted Iran's human trials research involving patients exposed to organophosphorous (OP) compounds in pesticides and development of treatment creams - research activities that could also be used in the event of OP nerve agent exposure. This type of information enabled IC customers, such as NCMI(National Center for Medical Intelligence) and NGIC(National Ground Intelligence Center), to assess the types of medical countermeasures being developed by Iran, as well as Iran's ability to respond to and protect against CBW threats. (Based on 3/00/501828-13, 3/00/505615-13, 3/00/507257-13, 3/00/507263-13, and 3/00/507268-13.)